Murphy et al. [20] reported increased levels of serum cartilage oligomeric matrix protein (COMP), a biomarker indicative of cartilage degradation, in subjects with (n = 18) and without (n = 14) chondromalacia patella (another term used to describe PFP). Here, COMP is linked to chondromalacia.